(Press-News.org) Every year in Belgium, 1,600 people wait for a transplant. Of these, in 2021, only 939 received an organ. Thus more than 40% of patients often have to wait more than a year before hoping to receive a transplant. When a transplant is possible, it is essential to ensure its success so as not to “waste” an organ. One of the keys to successful transplants is an anti-rejection drug, tacrolimus, which patients must take for life. But it is extremely difficult to dose this drug correctly, which can lead to significant risks of transplant failure in the event of underdosing and significant side effects in the event of overdosing (diabetes, hirsutism, hair loss, neuropathy or nephrotoxic effects).
Profs Laure Bindels and Laure Elens of the University of Louvain (UCLouvain) Louvain Drug Research Institute, supported by Alexandra Degraeve, a UCLouvain FNRS candidate, have been looking into the links between the drug, its dosages, and intestinal microbiota. Their aim has been to determine the factors that influence how the body absorbs and eliminates the drug during transplants. The results of five years of research have been published in the scientific journal Microbiome.
Research using mice
Prof. Bindels began the research using mice, with the goal of determining whether or not the presence of microbiota plays a role in drug absorption. The result was a world first: the UCLouvain researchers observed that without microbiota, tacrolimus levels in the mice’s blood were lower. This means that the presence of microbiota increases the drug’s concentration in the blood, thereby either reducing the risk of transplant rejection or, conversely, increasing the risk of side effects.
The research also uncovered an as yet unknown mechanism: microbiota promote drug absorption by reducing the action of a protein, P-glycoprotein, which acts like a pump on the surface of intestinal cells and limits the absorption of many drugs, including tacrolimus.
Clinical research
At the same time, in collaboration with Profs Michel Mourad and Vincent Haufroid of the UCLouvain Saint-Luc University Hospital, Prof. Elens carried out clinical tests on faecal matter taken from some 100 patients who had undergone kidney transplants. The goal was to understand the reasons for the wide variability in current tacrolimus dosages (from a factor of one to 30) from one patient to another, by revealing the composition of renal transplant patients’ microbiota.
The clinical tests showed that the higher the drug’s dosage, the less rich the microbiota (less diverse in bacteria). The research also identified two specific types of bacteria associated with a reduction in the required dosage of tacrolimus. Finally, tests revealed that patients who developed diabetes after taking tacrolimus routinely showed a reduction in a certain type of bacteria (Anaerostipes) in their microbiota, which could indicate the bacteria protects patients from developing diabetes.
What’s next? UCLouvain researchers have obtained funding from the FNRS to study microbiota over a long period, in order to make comparisons before, just after and at intervals from the transplant, and thus gain an even more accurate picture of the interactions between intestinal bacteria and the absorption of certain drugs, such as tacrolimus. The concept is also being applied to other drugs (anti-HIV, hypotensive drugs, etc.) pumped away by P-glycoprotein.
This discovery also demonstrates the importance of better communication between medical specialities: in the future, if a patient who has undergone a kidney transplant is required to take antibiotics (which have a significant impact on microbiota), it would be useful for contact to be made with their nephrologist beforehand in order to minimise side effects or problems of transplant rejection. Similar considerations apply to major dietary changes.
END
A first for UCLouvain in the fight against organ transplant rejection
2023-07-06
ELSE PRESS RELEASES FROM THIS DATE:
Giant stone artefacts found on rare Ice Age site in Kent
2023-07-06
UCL press release
Under embargo until Thursday, 6 July 2023, 00:01 London time
Giant stone artefacts found on rare Ice Age site in Kent
Researchers at the UCL Institute of Archaeology have discovered some of the largest early prehistoric stone tools in Britain.
The excavations, which took place in Kent and were commissioned in advance of development of the Maritime Academy School in Frindsbury, revealed prehistoric artefacts in deep Ice Age sediments preserved on a hillside above the Medway Valley.
The researchers, from UCL Archaeology South-East, discovered 800 stone artefacts thought to be over 300,000 years old, buried in sediments which filled a sinkhole and ...
New ferroelectric material could give robots muscles
2023-07-06
UNVERSITY PARK, Pa. — A new type of ferroelectric polymer that is exceptionally good at converting electrical energy into mechanical strain holds promise as a high-performance motion controller or “actuator” with great potential for applications in medical devices, advanced robotics, and precision positioning systems, according to a team of international researchers led by Penn State.
Mechanical strain, how a material changes shape when force is applied, is an important property for an actuator, which is any material that will change or deform when an external force such as electrical energy is applied. Traditionally, these actuator ...
CAMRE helps marines take 3D printing to new heights
2023-07-06
The Consortium for Additive Manufacturing Research and Education (CAMRE) at the Naval Postgraduate School (NPS) achieved the first successful demonstration of in-flight 3D printing aboard a U.S. Marine Corps MV-22 Osprey tiltrotor aircraft on June 21 in Southern California.
CAMRE’s operational demonstration, which involved the printing of a medical cast aboard an airborne Osprey, was part of larger-scale exercise support provided by CAMRE and the Marine Innovation Unit (MIU) to forces participating in an integrated training exercise (ITX) at Marine Corps Air Ground Combat Center Twentynine Palms, Calif., from June 10-22.
This successful test of in-flight ...
More IVF babies born after egg collection in summer rather than in autumn
2023-07-06
The time of year when eggs are collected from women’s ovaries during fertility treatment makes a difference to live birth rates, according to new research published today (Thursday) in Human Reproduction [1], one of the world’s leading reproductive medicine journals.
Researchers in Australia have found that transferring frozen then thawed embryos to women’s wombs from eggs collected in the summer resulted in a 30% higher likelihood of babies born alive, than if the eggs had been retrieved in the autumn.
Dr Sebastian Leathersich, an obstetrician, gynaecologist and Fellow in Reproductive Endocrinology and Infertility at Fertility Specialists of Western Australia, ...
International migrants left behind in HIV response: study
2023-07-06
International migrants in Australia and beyond are at increased risk of HIV infection due to reduced access to a highly effective prevention measure, a world-first global review led by Monash University has found.
Pre-exposure prophylaxis (PrEP) is up to 99 per cent effective in preventing HIV. The antiretroviral tablet is available by prescription and taken to prevent HIV infection.
Published in The Lancet Public Health, the study identified barriers that migrant populations in Australia and around the world face to access PrEP.
Multiple barriers included ...
Invasive non-native species cost UK economy an estimated £4bn a year, new CABI-led study reveals
2023-07-06
CABI scientists have carried out a study which reveals invasive non-native species (INNS) – such as the aquatic water weeds floating pennywort and Japanese knotweed as well as signal crayfish – cost the UK economy an estimated £4bn a year.
However, when species only covered by the GB Non-native Species Strategy are considered – for instance with fungi excluded from the estimate – the total cost was estimated to be £1.9bn.
Researchers working from CABI’s centres in Egham, UK, as well as Switzerland and Kenya, found a 135% increase in comparable costs since the last assessment was conducted in 2010. Annual estimated costs in 2021 were £3.02bn, ...
Empowering vulnerable communities in the face of growing natural threats
2023-07-06
Heavy wildfire smoke drifting from Canada to U.S. cities hundreds of miles away is a stark reminder that no community is immune from climate change-fueled hazards. A Stanford-led study published recently in Environmental Research Letters provides a blueprint for empowering people in frontline communities – those that experience the “first and worst” consequences of climate change – to better understand and deal with wildfire smoke, extreme heat, and other hazards.
The research – done in four predominantly low-income, ...
Fewer than half of new drugs add substantial therapeutic value over existing treatments
2023-07-06
New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).
But a study published by The BMJ today finds that less than half of approved first indications for new drugs in the US and Europe between 2011 and 2020 add substantial therapeutic value over existing treatments and only around a third of supplemental approvals add substantial therapeutic value compared with first approvals.
The researchers argue that when first or supplemental indications do not offer added benefit over existing treatments, this information should be clearly communicated to patients and reflected in the price of ...
Lack of sleep lessens cognitive benefits of physical activity
2023-07-06
Lack of sleep lessens cognitive benefits of physical activity
Regular physical activity may protect against cognitive decline as we get older, but this protective effect may be diminished for people who are not getting enough sleep, according to a new study by UCL researchers.
The study, published in The Lancet Healthy Longevity, looked at cognitive function over 10 years in 8,958 people aged 50 and over in England. The research team investigated how different combinations of sleep and physical activity habits might affect people’s cognitive function over time.
They found that people who were more physically ...
Amsterdam UMC led eHealth app ensures 30% faster recovery after major abdominal operations
2023-07-06
Through the use of eHealth application ikHerstel, patients recover from major abdominal operations 30% faster than patients who do not use the app. That is the main conclusion of research led by Amsterdam UMC across eleven Dutch hospitals. The app aims to empower patients to feel more in control of their recovery process. The results were published today in Lancet Digital Health.
Patients are being discharged from the hospital quicker after treatment. Where patients used to receive care, information and support in the hospital for a number of days, they are now often ...